In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Xenova Group plc offer for KS Biomedix Holdings plc
Xenova Licenses TA-CIN to Cancer Research Technology
Millennium and Xenova initiate Phase I clinical of MLN944
Physiome licenses biological modeling technology to 3rd Millennium
MILLENNIUM ADVANCES ONCOLOGY PIPELINE
Millennium in-licenses novel target for colorectal cancer
Xenova receive IND approval for XR9576